Vector Strategic Advisors

Vector Strategic Advisors provides licensing and commercial strategy advisory services to early-stage and mid-sized biopharmaceutical companies, investors, and academic institutions. The firm specializes in out-/in-license preparation, partner outreach, negotiation support, due diligence coordination, market analytics, and business development training. It does not conduct its own R&D or clinical trials but supports clients engaged in therapeutic R&D[1][2]. Vector Strategic Advisors is an active boutique advisory firm specializing in licensing and commercial strategy for early-stage to mid-sized biopharmaceutical companies. Founded by Patricia Sinatra in Silicon Valley/Bay Area in 2010, it offers services such as out-/in-license preparation/execution, partner outreach/support at partnering meetings, term sheet negotiation/development, valuation/forecasting analysis, due diligence coordination on both buy/sell sides of deals—as well as mentoring/business development instruction programs. The company has no internal drug pipeline or proprietary technology platforms but plays a strategic role supporting life science innovators with commercialization efforts.[1][2]